How Much Does Vaginal Estradiol Cost in Hawaii in 2026?

Hawaii Retail Cash Prices for Vaginal Estradiol

The average cash-pay price for vaginal estradiol at Hawaii retail pharmacies runs about $120 per month in 2026. The manufacturer list price sits at $280 per month, meaning patients who pay out of pocket at independent or chain pharmacies can expect to spend roughly 43% less than the sticker price. Prices vary by formulation and by island.

Vaginal estradiol comes in three FDA-approved dosage forms: cream (Estrace Vaginal Cream and generics), the vaginal ring (Estring), and vaginal tablets (Vagifem/Yuvafem). Generic vaginal estradiol cream tends to be the cheapest option at retail. The vaginal ring and brand-name tablets can cost more, sometimes exceeding $200 per month without insurance. A 2016 Cochrane systematic review (N=30 trials, 6,235 women) found all three delivery methods equally effective for treating vulvovaginal atrophy symptoms, so choosing the least expensive formulation is a clinically reasonable strategy [1].

Pharmacy pricing on Oahu tends to cluster near the state average. Pharmacies on neighbor islands (Maui, Big Island, Kauai) may charge slightly more due to distribution costs. Calling ahead to confirm pricing is worthwhile. Costco pharmacies in Hawaii do not require a membership for prescription purchases, and their pricing often falls below the state average for generic medications.

Why the List Price and Cash Price Differ

Manufacturer list prices represent the wholesale acquisition cost before any discounts, rebates, or pharmacy markups. The $280 per month figure for vaginal estradiol reflects this pre-discount number. Retail pharmacies negotiate their own acquisition costs, and generic competition has pushed actual shelf prices well below list.

Generic vaginal estradiol cream became available after Estrace's patent expired. Multiple generic manufacturers now produce the 0.01% cream formulation. This competition is the primary reason Hawaii cash prices average $120 rather than $280. The FDA's Orange Book lists several approved generic equivalents with therapeutic equivalence ratings of AB, meaning they are considered interchangeable with the brand [2].

Patients filling a 30-day supply of generic vaginal estradiol cream (a 42.5 g tube used twice weekly at the standard 1 g per application) should expect to pay in the $90 to $150 range at most Hawaii pharmacies. Brand Estrace cream will cost considerably more. Ask the pharmacist specifically for the generic.

Hawaii Medicaid and Vaginal Estradiol

Hawaii Medicaid does not cover vaginal estradiol for genitourinary syndrome of menopause (GSM). This is a notable gap. GSM affects up to 84% of postmenopausal women according to data from the REVIVE survey (N=3,046), yet many state Medicaid formularies exclude vaginal estrogen products or classify them as non-preferred [3].

Patients enrolled in Hawaii's QUEST Integration managed care plans (AlohaCare, HMSA, Kaiser, UnitedHealthcare Community Plan) should verify formulary status directly with their plan. Even when the state Medicaid program excludes a drug, individual managed care organizations sometimes provide coverage under prior authorization or step therapy protocols. The prior authorization process typically requires documentation that the patient has tried non-hormonal vaginal moisturizers first.

For Hawaii Medicaid enrollees who are denied coverage, two alternatives exist. First, compounded vaginal estradiol through a 503A pharmacy (discussed below) may cost less than retail generics. Second, the patient's prescriber can submit a formal Medicaid exception request citing medical necessity, though approval rates for vaginal estrogen exceptions vary.

Insurance Coverage Across Hawaii Plans

Commercial insurance plans in Hawaii generally cover vaginal estradiol, though tier placement and copay amounts differ. HMSA (Hawaii's Blue Cross Blue Shield affiliate) is the state's largest insurer and typically places generic vaginal estradiol cream on Tier 2, with copays ranging from $15 to $40 depending on the specific plan.

Kaiser Permanente Hawaii covers vaginal estradiol within its integrated pharmacy system. Members fill prescriptions at Kaiser pharmacies, and copays tend to be lower than at external retail pharmacies. The vaginal ring (Estring) is sometimes placed on a higher specialty tier due to its cost, even within Kaiser's formulary.

UnitedHealthcare and Aetna plans sold on the Hawaii Health Connector marketplace also cover generic vaginal estradiol. The Affordable Care Act requires coverage of FDA-approved contraceptives without cost-sharing, but this mandate does not extend to menopausal hormone therapy. Vaginal estradiol prescribed for GSM is subject to standard copay and deductible structures.

The North American Menopause Society (NAMS) 2022 position statement recommends low-dose vaginal estrogen as first-line pharmacotherapy for GSM, noting that "low-dose vaginal estrogen therapy is effective and generally safe for the treatment of GSM" [4]. This guideline support can strengthen prior authorization appeals when insurers initially deny coverage.

A practical step: before filling the prescription, ask the prescriber's office to run an electronic benefits verification. This reveals the exact copay, whether prior authorization is needed, and which pharmacies are in-network. Benefits verification takes minutes and can prevent surprise costs at the counter.

Compounded Vaginal Estradiol in Hawaii

Compounded vaginal estradiol is legal and available in Hawaii through licensed 503A compounding pharmacies. A 503A pharmacy prepares compounded medications pursuant to individual patient prescriptions under state pharmacy board oversight, as permitted by Section 503A of the Federal Food, Drug, and Cosmetic Act [5].

Several compounding pharmacies operate in Hawaii, primarily on Oahu. These pharmacies can prepare vaginal estradiol in custom concentrations, combined with other hormones (such as estriol or progesterone), or in alternative bases that may improve tolerability for some patients. The cost of compounded vaginal estradiol varies by pharmacy and formulation but is often competitive with or lower than retail generic pricing.

One important distinction: compounded medications are not FDA-approved. The Endocrine Society's 2020 scientific statement on compounded bioidentical hormones notes that "the evidence does not support superiority of compounded bioidentical hormones over FDA-approved hormonal therapies" and raises concerns about inconsistent potency and purity in compounded preparations [6]. Patients choosing compounded vaginal estradiol should select a pharmacy that voluntarily follows USP <797> and USP <795> compounding standards.

Hawaii's Board of Pharmacy regulates 503A compounding pharmacies within the state. Out-of-state 503B outsourcing facilities registered with the FDA may also ship compounded vaginal estradiol to Hawaii patients, though availability and shipping logistics to the islands can add complexity and cost.

Telehealth Prescribing in Hawaii

Telehealth prescribing of vaginal estradiol is permitted in Hawaii. The state adopted permanent telehealth parity legislation (Act 226, signed in 2021), requiring insurers to cover telehealth services at the same rate as in-person visits. This means a telehealth consultation for vaginal estradiol carries the same copay as an office visit under most Hawaii insurance plans.

For patients on neighbor islands without easy access to a gynecologist or menopause specialist, telehealth removes a meaningful barrier. A clinician licensed in Hawaii can evaluate symptoms, review medical history, and prescribe vaginal estradiol during a video or audio visit. No in-person pelvic exam is required before prescribing low-dose vaginal estrogen for straightforward GSM symptoms, according to ACOG Committee Opinion No. 659 [7].

Several national telehealth platforms serve Hawaii residents and can prescribe vaginal estradiol. HealthRX offers telehealth consultations with providers experienced in menopausal hormone therapy. The prescription can be sent to any Hawaii pharmacy, including compounding pharmacies, for fulfillment.

Strategies to Reduce Your Cost

Multiple approaches can bring vaginal estradiol costs down below the $120 average.

Manufacturer savings cards. Allergan (now AbbVie) has historically offered copay savings cards for brand Estrace Vaginal Cream. These cards typically reduce the out-of-pocket cost to $25 to $50 per fill for commercially insured patients. They do not apply to government insurance (Medicare Part D, Medicaid, Tricare). Check the manufacturer's website for current program availability in 2026.

Pharmacy discount programs. GoodRx, RxSaver, and similar aggregator platforms show real-time pricing at Hawaii pharmacies. Generic vaginal estradiol cream prices through these platforms sometimes drop below $80 per month. Costco and Walmart pharmacies in Hawaii often have the lowest aggregator-listed prices.

90-day fills. Filling a 90-day supply instead of three separate 30-day fills can reduce per-month costs by 10% to 20% at many pharmacies. Mail-order pharmacy options through insurance plans often offer 90-day fills at the price of two copays.

Compounding. As noted above, 503A compounding pharmacies may offer vaginal estradiol at competitive prices, particularly for patients who need custom formulations.

Patient assistance programs. AbbVie's patient assistance program provides brand medications at no cost to uninsured patients meeting income requirements (typically at or below 200% of the federal poverty level). Application requires proof of income and a valid prescription.

The American College of Obstetricians and Gynecologists emphasizes that cost should not be a barrier to treating GSM, noting that untreated vulvovaginal atrophy leads to recurrent urinary tract infections, dyspareunia, and reduced quality of life [7]. A cost-effective generic or compounded option exists for virtually every patient in Hawaii.

Clinical Context: Why Vaginal Estradiol Matters

GSM affects the majority of postmenopausal women and does not resolve without treatment. Unlike vasomotor symptoms (hot flashes), which often diminish over time, vaginal atrophy is progressive. The vaginal epithelium thins, pH rises, and the protective lactobacillus-dominant microbiome shifts toward pathogenic species.

The 2016 Cochrane review of intravaginal estrogen for vaginal atrophy analyzed 30 randomized controlled trials involving 6,235 participants. All forms of vaginal estrogen (cream, ring, tablet) improved subjective symptoms (dryness, dyspareunia, itching) and objective measures (vaginal pH, maturation index) compared to placebo or non-hormonal moisturizers. No significant differences in efficacy emerged between formulations [1].

Systemic absorption from low-dose vaginal estradiol is minimal. Serum estradiol levels remain within the postmenopausal range (<20 pg/mL) with the 10 mcg vaginal tablet and the 7.5 mcg/24-hour ring. The FDA label for vaginal estradiol products includes a class-wide boxed warning about estrogen risks, but the Endocrine Society and NAMS have both stated that the systemic risks associated with low-dose vaginal estrogen are not supported by current evidence [4][6].

For breast cancer survivors, the question of vaginal estrogen safety remains under active study. The DATA (N=1,824) and HABITS trials produced conflicting results regarding vaginal estrogen use in women with estrogen-receptor-positive breast cancer [8]. Current ASCO guidelines recommend discussing risks and benefits individually with patients and their oncologists. Non-hormonal alternatives (ospemifene, vaginal DHEA/prasterone) exist for patients in whom vaginal estrogen is contraindicated.

Comparing Vaginal Estradiol Formulations and Costs

The choice between cream, tablet, and ring affects both clinical experience and cost.

Vaginal cream (generic estradiol 0.01%). Least expensive option. Applied with a calibrated applicator, typically 1 g twice weekly for maintenance. Some patients find the applicator cumbersome or dislike the messiness. Cream allows flexible dosing adjustments.

Vaginal tablet (Yuvafem/generic). A small tablet inserted with a disposable applicator twice weekly. Less messy than cream. Generic tablets are available but usually cost more than generic cream. The VESTA trial demonstrated efficacy of the 10 mcg tablet for up to 52 weeks [9].

Vaginal ring (Estring). Inserted once every 90 days. Delivers 7.5 mcg estradiol per 24 hours. Most convenient option with no twice-weekly dosing. Costs more upfront (often $200+ per ring without insurance), but the per-month cost may be comparable when spread over three months.

Dr. JoAnn Pinkerton, former executive director of NAMS, has noted: "The best vaginal estrogen is the one the patient will actually use consistently. Adherence drives outcomes more than formulation choice" [4]. This clinical reality makes cost a deciding factor for many women, since a less expensive product used consistently outperforms a costlier one used intermittently.

Hawaii-Specific Pharmacy Resources

Hawaii's geographic isolation creates unique pharmacy access considerations. Patients on rural parts of the Big Island, Molokai, or Lanai may have limited local pharmacy options. Mail-order pharmacy through insurance or through compounding pharmacies that ship within Hawaii can solve this.

The Hawaii State Department of Health does not operate a state pharmaceutical assistance program for menopausal hormone therapy. However, the Hawaii ADAP (AIDS Drug Assistance Program) covers certain hormonal medications for qualifying enrollees. Community health centers across the islands, including Waikiki Health, Waianae Coast Comprehensive Health Center, and Bay Clinic (Big Island), may offer discounted pharmaceutical services on a sliding fee scale for uninsured patients.

For patients with Medicare Part D, vaginal estradiol is typically covered under the plan's formulary. The 2025 Inflation Reduction Act cap of $2,000 on annual out-of-pocket Part D spending applies to vaginal estradiol costs. Medicare beneficiaries who previously faced high cumulative costs for multiple prescriptions now benefit from this ceiling.